Waldron Private Wealth’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,946
Closed -$272K 495
2024
Q2
$272K Sell
2,946
-440
-13% -$39K 0.01% 332
2024
Q1
$324K Sell
3,386
-87
-3% -$7.31K 0.01% 299
2023
Q4
$265K Sell
3,473
-751
-18% -$52.3K 0.01% 335
2023
Q3
$293K Buy
4,224
+80
+2% +$6.43K 0.02% 294
2023
Q2
$391K Sell
4,144
-257
-6% -$22.3K 0.02% 259
2023
Q1
$364K Buy
4,401
+231
+6% +$18.2K 0.02% 299
2022
Q4
$344K Hold
4,170
0.02% 286
2022
Q3
$344K Buy
4,170
+411
+11% +$39.5K 0.02% 286
2022
Q2
$357K Sell
3,759
-212
-5% -$21.9K 0.02% 280
2022
Q1
$467K Buy
3,971
+301
+8% +$33.8K 0.02% 260
2021
Q4
$475K Buy
3,670
+17
+0.5% +$1.98K 0.02% 254
2021
Q3
$413K Buy
3,653
+893
+32% +$102K 0.02% 243
2021
Q2
$285K Sell
2,760
-2
-0.1% -$189 0.02% 282
2021
Q1
$231K Sell
2,762
-435
-14% -$36.8K 0.02% 276
2020
Q4
$291K Buy
3,197
+416
+15% +$34.5K 0.02% 232
2020
Q3
$221K Buy
+2,781
New +$217K 0.02% 244
2020
Q1
Sell
-2,817
Closed -$219K 262
2019
Q4
$219K Buy
+2,817
New +$220K 0.02% 247

Other funds holding EW

Waldron Private Wealth's EW Position: Q3 2024 in Review

Waldron Private Wealth sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 2,946 shares — an estimated $272K sold.

Waldron Private Wealth first reported a position in EW in Q4 2019 and held it in 17 quarters. The position peaked at $475K in Q4 2021. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Waldron Private Wealth reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Waldron Private Wealth sold 2,946 Edwards Lifesciences shares in Q3 2024, an estimated $272K.
  • Waldron Private Wealth first reported a position in Edwards Lifesciences in Q4 2019 and held it in 17 quarters.
  • Waldron Private Wealth's Edwards Lifesciences position peaked at $475K in Q4 2021.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Waldron Private Wealth's 13F filing for Q3 2024, filed 21 Oct 2024.